Bajaj Healthcare Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Bajaj Healthcare Ltd is ₹ 323.8 as of 05 May 15:30 . The P/E Ratio of Bajaj Healthcare Ltd changed from 7.8 on March 2021 to 53.7 on March 2025 . This represents a CAGR of 47.09% over 5 yearsThe P/E Ratio of Shree Ganesh Biotech India Ltd changed from 740.6 on March 2021 to 90 on March 2025 . This represents a CAGR of -34.40% over 5 years The Market Cap of Bajaj Healthcare Ltd changed from ₹ 650.77 crore on March 2021 to ₹ 2121 crore on March 2025 . This represents a CAGR of 26.66% over 5 yearsThe Market Cap of Shree Ganesh Biotech India Ltd changed from ₹ 236.18 crore on March 2021 to ₹ 35.88 crore on March 2025 . This represents a CAGR of -31.40% over 5 years The revenue of Bajaj Healthcare Ltd for the Dec '25 is ₹ 162.87 crore as compare to the Sep '25 revenue of ₹ 149.57 crore. This represent the growth of 8.89% The revenue of Shree Ganesh Biotech India Ltd for the Dec '25 is ₹ 1.07 crore as compare to the Sep '25 revenue of ₹ 1.18 crore. This represent the decline of -9.32% The ebitda of Bajaj Healthcare Ltd for the Dec '25 is ₹ 31.9 crore as compare to the Sep '25 ebitda of ₹ 27.26 crore. This represent the growth of 17.02% The ebitda of Shree Ganesh Biotech India Ltd for the Dec '25 is ₹ 0.32 crore as compare to the Sep '25 ebitda of ₹ 0.01 crore. This represent the growth of 3100% The net profit of Bajaj Healthcare Ltd changed from ₹ 7.13 crore to ₹ 15.67 crore over 7 quarters. This represents a CAGR of 56.83% The net profit of Shree Ganesh Biotech India Ltd changed from ₹ 0.24 crore to ₹ 0.32 crore over 7 quarters. This represents a CAGR of 17.87% The Dividend Payout of Bajaj Healthcare Ltd changed from 4.57 % on March 2021 to 7.99 % on March 2025 . This represents a CAGR of 11.82% over 5 yearsThe Dividend Payout of Shree Ganesh Biotech India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bajaj Healthcare Ltd

Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers.
The Company is engaged in the manufacturing and exporting of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals. Company commenced its operations in 1993 with a single unit at Tarapur.
It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities.
In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility.

About Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' with the Registrar of Companies, West Bengal.
The Company got the Certificate of Commencement of Business on September 14, 1982.
The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business. In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010.
The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited.
Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited.

FAQs for the comparison of Bajaj Healthcare Ltd and Shree Ganesh Biotech India Ltd

Which company has a larger market capitalization, Bajaj Healthcare Ltd or Shree Ganesh Biotech India Ltd?

Market cap of Bajaj Healthcare Ltd is 1,090 Cr while Market cap of Shree Ganesh Biotech India Ltd is 25 Cr

What are the key factors driving the stock performance of Bajaj Healthcare Ltd and Shree Ganesh Biotech India Ltd?

The stock performance of Bajaj Healthcare Ltd and Shree Ganesh Biotech India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bajaj Healthcare Ltd and Shree Ganesh Biotech India Ltd?

As of May 5, 2026, the Bajaj Healthcare Ltd stock price is INR ₹323.8. On the other hand, Shree Ganesh Biotech India Ltd stock price is INR ₹0.63.

How do dividend payouts of Bajaj Healthcare Ltd and Shree Ganesh Biotech India Ltd compare?

To compare the dividend payouts of Bajaj Healthcare Ltd and Shree Ganesh Biotech India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.